Orqis Begins Cancion Therapy Trial Enrollment, Mulls Future Indications

Orqis Medical has enrolled the first patient in the MOMENTUM pivotal trial of its Cancion CRS cardiac recovery system, according to Medical Director Marvin Konstam, MD, Tufts-New England Medical Center

More from Archive

More from Medtech Insight